USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.18 | $-0.24 | $-0.22 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $0.00 | $0.00 | $0.00 |
Allena Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.19 | $-0.21 | $-0.15 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.81 | $-0.84 | $-0.75 |
| Dec 2022 | 4 | $-0.71 | $-0.75 | $-0.66 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.19 | $-0.19 | $-0.21 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.81 | $-0.78 | $-0.83 |
| Dec 2022 | 0 / 0 | $-0.71 | $-0.70 | $-0.98 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 4 | $2.50M | $0.00 | $10.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.18 | - | - |
| Aug 10, 2021 | Jun 2021 | $-0.20 | $-0.24 | -20.00% |
| May 11, 2021 | Mar 2021 | $-0.21 | $-0.21 | -1.60% |
| Mar 9, 2021 | Dec 2020 | $-0.19 | $-0.24 | -29.73% |
| Nov 9, 2020 | Sep 2020 | $-0.21 | $-0.22 | -5.52% |
| Aug 5, 2020 | Jun 2020 | $-0.29 | $-0.26 | 9.09% |
| May 13, 2020 | Mar 2020 | $-0.43 | $-0.31 | 27.35% |
| Mar 16, 2020 | Dec 2019 | $-0.55 | $-0.46 | 16.26% |
| Nov 13, 2019 | Sep 2019 | $-0.50 | $-0.57 | -13.91% |
| Aug 7, 2019 | Jun 2019 | $-0.56 | $-0.54 | 3.00% |
| May 8, 2019 | Mar 2019 | $-0.49 | $-0.55 | -12.50% |
| Mar 7, 2019 | Dec 2018 | $-0.50 | $-0.46 | 8.60% |
| Nov 7, 2018 | Sep 2018 | $-0.46 | $-0.46 | - |
| Aug 7, 2018 | Jun 2018 | $-0.39 | $-0.42 | -7.14% |
| May 8, 2018 | Mar 2018 | $-0.41 | $-0.38 | 7.77% |
| Mar 27, 2018 | Dec 2017 | $-0.54 | $-0.48 | 10.70% |
| Dec 14, 2017 | Sep 2017 | $-0.31 | $-0.30 | 3.23% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 9, 2021 | Dec 2020 | $-0.94 | $-1.03 | - |
| Mar 16, 2020 | Dec 2019 | $-2.10 | $-2.12 | - |
| Mar 7, 2019 | Dec 2018 | $-1.76 | $-1.72 | - |
| Mar 27, 2018 | Dec 2017 | $-3.19 | $-0.78 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 10, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 11, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 9, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 9, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 5, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 13, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 16, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 13, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 7, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 8, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 7, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 7, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 7, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 8, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Mar 27, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Dec 14, 2017 | Sep 2017 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 9, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 16, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 7, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Mar 27, 2018 | Dec 2017 | $0.00 | $0.00 | - |
ALNA's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 4 analysts, the average EPS estimation for Allena Pharmaceuticals's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.19, and a high estimation of $-0.18.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.18, and the 3 month trend is $-0.21.
Based on 4 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Allena Pharmaceuticals's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.
ALNA's earnings per share (EPS) was $-0.24, missing the consensus analysts forecast of $-0.20 by -20.00%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 14.29%, and higher than the same period a year before (Jun 2020) by -7.69%.
Revenues were $0.00.
The company reported a net income of $-13.97M.Free cash flow for the quarter was $-11.40M , compared to $-10.46M last quarter and $-6.72M a year before.
ALNA ended the quarter with $10.52M in total debt, an increase of 0.45% compared to the previous quarter, and an increase of 27.07% compared to the same quarter a year before.
Allena Pharmaceuticals's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.
ALNA's earnings per share (EPS) was $-1.03, missing the consensus analysts forecast of $-0.94 by 9.57% , and higher than the previous year's EPS (Dec 2019) by -51.36%.
Revenues were $0.00.
The company reported a net income of $-32.84M.
Allena Pharmaceuticals reported a free cash flow of $-28.81M for its fiscal year, compared to $-43.75M a year ago.
The company ended the fiscal year with $10.14M in total debt, a decrease of -3.19% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.